LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Docosahexaenoic acid neurolipidomics.

    Niemoller, Tiffany D / Bazan, Nicolas G

    Prostaglandins & other lipid mediators

    2009  Volume 91, Issue 3-4, Page(s) 85–89

    Abstract: Mediator lipidomics is a field of study concerned with the characterization, structural elucidation and bioactivity of lipid derivatives actively generated by enzymatic activity. It is well known that omega-3 fatty acids are beneficial for brain function. ...

    Abstract Mediator lipidomics is a field of study concerned with the characterization, structural elucidation and bioactivity of lipid derivatives actively generated by enzymatic activity. It is well known that omega-3 fatty acids are beneficial for brain function. Docosahexaenoic acid [DHA; 4 22:6(n-3)] is the most abundant essential omega-3 fatty acid present in the brain and it has multiple mechanisms of exerting protective effects after cellular injury. Certain lipid species produced from DHA early during the reperfusion stage of brain ischemia-reperfusion injury are generated in order to help the cell cope as the injury progresses. We explore these newly discovered lipid mediators in order to understand their role in the cell. We have identified one of these potentially protective lipid mediators as a novel stereospecific DHA-derived fatty acid, called neuroprotectin D1 (NPD1; 10R,17S-dihydroxy-docosa-4Z,7Z,11E,15E,19Z hexaenoic acid). DHA also has important roles in pro-survival signaling cascades after ischemia-reperfusion in injury. It has been shown to accelerate AKT translocation and activation and has binding affinity with an important PPAR-gamma family of ligand-activated nuclear receptors that have been implicated in various aspects of lipid metabolism and have been shown to have anti-inflammatory actions. Here we present an overview of these mechanisms and discuss the potential of using DHA signaling in the development of treatments for the large population of patients suffering from the devastating consequences of stroke.
    MeSH term(s) Animals ; Docosahexaenoic Acids/metabolism ; Humans ; Lipid Metabolism ; Nervous System/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Stroke/chemically induced ; Stroke/metabolism
    Chemical Substances protectin D1 ; Docosahexaenoic Acids (25167-62-8) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Language English
    Publishing date 2009-10-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1426962-4
    ISSN 2212-196X ; 1098-8823 ; 0090-6980
    ISSN (online) 2212-196X
    ISSN 1098-8823 ; 0090-6980
    DOI 10.1016/j.prostaglandins.2009.09.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Omega-3 fatty acid docosahexaenoic acid is the precursor of neuroprotectin D1 in the nervous system.

    Niemoller, Tiffany D / Stark, David T / Bazan, Nicolas G

    World review of nutrition and dietetics

    2009  Volume 99, Page(s) 46–54

    MeSH term(s) Brain/physiology ; Diet ; Docosahexaenoic Acids/administration & dosage ; Docosahexaenoic Acids/metabolism ; Epilepsy ; Humans ; Neurodegenerative Diseases/prevention & control ; Neuronal Plasticity ; Neuroprotective Agents ; Reperfusion Injury ; Retina/physiology
    Chemical Substances Neuroprotective Agents ; protectin D1 ; Docosahexaenoic Acids (25167-62-8)
    Language English
    Publishing date 2009-01-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ISSN 1662-3975 ; 0084-2230 ; 0512-3593
    ISSN (online) 1662-3975
    ISSN 0084-2230 ; 0512-3593
    DOI 10.1159/000192994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top